Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU 37

37 - Factors predicting metastatic disease in 68Ga-PSMA-11 PET positive osseous lesions in prostate cancer (ID 1231)

Session Name
Prostate: PSMA PET in biochemical recurrence
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU
Presentation Number
37

Previous Eposter
36 - Low-dose TRT reshapes the microenvironment of prostate tumors to potentiate response to immunotherapy (ID 14)

Next Eposters
38 - Diagnostic Performance of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the Phase 3, Multicenter CONDOR Study (ID 1227)
39 - Survey by the French Medicine Agency (ANSM) of the practice, result and impact of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer with non-contributive 18F-fluorocholine PET/CT: 1177 examinations (ID 1234)
40 - Preliminary results of a prospective, multicenter trial assessing the impact of 18F-DCFPyL-PET/CT on the management of patients with recurrent prostate cancer. (ID 1228)
41 - Incidence of local prostate cancer recurrence by 68Ga-PSMA-11 PET/CT is higher after definitive Radiation Therapy than after Radical Prostatectomy: a single center post-hoc retrospective analysis of recurrence patterns of 787 patients. (ID 1233)
42 - Matched-pair comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in patients with primary and biochemical recurrent prostate cancer (ID 1229)
43 - Impact of68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial (ID 1232)
44 - Combined value of PSMA-based 18F-DCFPyL, 18F-FDG and 18F-NaF PET/CT imaging in metastatic prostate cancer patients (ID 1230)
45 - The effect of changes of serum thyrotropin receptor antibody on the outcome of radioactive iodide therapy for Graves’ hyperthyroidism (ID 283)
46 - Visceral fat metabolic activity evaluated by 18F-FDG PET/CT predicts osteoporosis in healthy postmenopausal Korean women (ID 284)
48 - Comparison of 125I-BMIPP-SPECT/CT to 18F-FDG-PET/CT for imaging brown fat in a preclinical model (ID 281)